Different H–2 subregions influence immunization against retrovirus and immunosuppression
- 22 October 1987
- journal article
- Published by Springer Nature in Nature
- Vol. 329 (6141) , 729-732
- https://doi.org/10.1038/329729a0
Abstract
Friend murine leukaemia virus complex (FV) causes an immunosuppressive retrovirus-induced disease. In certain mouse strains, FV shows striking similarities to human immunodeficiency virus (HIV) infection in man in that infected mice have severe T-cell immunosuppression but also develop virus-neutralizing antibodies incapable of eliminating infected cells. Previously we noted the influence of mouse major histocompatibility complex (H-2) genes on both FV-induced immunosuppression and on ability to protect mice against FV by immunizing with a vaccinia-Friend murine leukaemia helper virus (F-MuLV) envelope (env) recombinant virus. Here we show that different subregions of H-2 are involved in susceptibility to virus-induced immunosuppression (H-2D subregion) and protective immunization with a recombinant vaccinia virus (H-2K or I-A subregions). Thus, susceptibility to virus-induced immunosuppression does not preclude protection by vaccinia-Friend immunization. The mechanism of protection seems to involve priming of immune T cells, and not initial induction of neutralizing antibodies or cytotoxic T lymphocytes (CTL) (ref.2). Subsequent virus challenge generates a secondary response, resulting in appearance of IgG antibodies and CTL. In human HIV infection there could also be host genetic influences on elements of disease pathogenesis, such as immunosuppression, and on the success of T-cell priming by potential protective vaccines.Keywords
This publication has 23 references indexed in Scilit:
- T-Lymphocyte Priming and Protection Against Friend Leukemia by Vaccinia-Retrovirus env Gene RecombinantScience, 1986
- Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression.The Journal of Experimental Medicine, 1986
- Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patientsNature, 1985
- Vaccinia Virus Recombinant Expressing Herpes Simplex Virus Type 1 Glycoprotein D Prevents Latent Herpes in MiceScience, 1985
- H-2D control of recovery from Friend virus leukemia: H-2D region influences the kinetics of the T lymphocyte response to Friend virus.The Journal of Experimental Medicine, 1983
- Antibodies to Cell Membrane Antigens Associated with Human T-Cell Leukemia Virus in Patients with AIDSScience, 1983
- Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production.The Journal of Experimental Medicine, 1979
- Antibody-induced loss of Friend virus leukemia cell surface antigens occurs during progression of erythroleukemia in F1 mice.The Journal of Experimental Medicine, 1978
- Studies on the role of the host immune response in recovery from Friend virus leukemia. I. Antiviral and antileukemia cell antibodies.The Journal of Experimental Medicine, 1976
- HOST GENETIC CONTROL OF RECOVERY FROM FRIEND LEUKEMIA VIRUS-INDUCED SPLENOMEGALYThe Journal of Experimental Medicine, 1974